JXR Buys Back 1.14 Million Shares on 19 May; Pending Cancellations Climb to 31.89 Million

Bulletin Express05-19

Jinxin Fertility Group Limited (abbrev. “JXR”) disclosed that it repurchased 1.14 million ordinary shares on the Hong Kong Exchange on 19 May 2026 at HKD 2.34–2.35 per share, spending HKD 2.67 million in aggregate. All repurchased shares are earmarked for cancellation.

Including this latest purchase, a total of 31.89 million shares bought between 27 March and 19 May 2026 remain pending cancellation. This represents approximately 1.18% of JXR’s current issued share base of 2.71 billion shares. Until cancellation is completed, the company’s issued share capital remains unchanged. JXR holds no treasury shares.

Under the shareholder mandate granted on 26 June 2025, the company may repurchase up to 274.47 million shares. After the latest transaction, 71.55 million shares—about 2.61% of the issued share count at the mandate date—have been repurchased, leaving an authorised balance of roughly 202.92 million shares.

The company is subject to a moratorium on issuing new shares or transferring any treasury shares until 18 June 2026, in line with Hong Kong Listing Rule 10.06(3)(a).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment